Form 8-K - Current report:
SEC Accession No. 0001104659-25-058908
Filing Date
2025-06-12
Accepted
2025-06-12 16:24:57
Documents
17
Period of Report
2025-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517546d1_8k.htm   iXBRL 8-K 52728
2 EXHIBIT 2.3 tm2517546d1_ex2-3.htm EX-2.3 59505
3 EXHIBIT 23.1 tm2517546d1_ex23-1.htm EX-23.1 3026
4 EXHIBIT 99.1 tm2517546d1_ex99-1.htm EX-99.1 9691
8 GRAPHIC tm2517546d1_ex23-1img001.jpg GRAPHIC 4437
9 GRAPHIC tm2517546d1_ex99-1img001.jpg GRAPHIC 2948
  Complete submission text file 0001104659-25-058908.txt   321712

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20250606.xsd EX-101.SCH 3035
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20250606_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20250606_pre.xml EX-101.PRE 22371
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2517546d1_8k_htm.xml XML 3345
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 251043067
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)